Effects of statins on myocardial and coronary artery response to ischemia-reperfusion

Stephen V Rendig1, J David Symons, Ezra A Amsterdam

  • 1Department of Internal Medicine, University of California, Davis 95616, USA.

Insights

Statins did not affect ventricular recovery after myocardial ischemia-reperfusion in pigs. However, statin treatment improved endothelium-dependent vasodilation in coronary arteries, potentially enhancing blood flow to ischemic regions.

Area of Science:

  • Cardiovascular Science
  • Pharmacology

Background:

  • Statins are widely used to manage hypercholesterolemia.
  • Their effects on myocardial ischemia-reperfusion injury and coronary vasodilation are not fully understood.
  • Lipophilic statins may have different effects than hydrophilic statins due to cell permeability.

Purpose of the Study:

  • To investigate if lipophilic statins impair ventricular recovery from ischemia-reperfusion compared to a hydrophilic statin.
  • To determine if statins enhance endothelium-dependent vasodilation in coronary arteries from ischemic regions.

Main Methods:

  • Farm pigs were treated with atorvastatin, pravastatin, simvastatin, or no statin for 3 weeks.
  • Left ventricular function was assessed during ischemia-reperfusion.
  • Coronary artery vasodilation and vasoconstriction were measured in isolated arteries from the ischemic region.

Main Results:

  • No significant differences in ventricular function recovery were observed among statin-treated groups and controls.
  • Bradykinin-induced vasorelaxation of coronary conductance vessels was greater in statin-treated pigs.
  • Acetylcholine-induced vasoconstriction was reduced in simvastatin-treated animals.

Conclusions:

  • Three weeks of atorvastatin, pravastatin, or simvastatin treatment did not alter ischemia-induced myocardial stunning in pigs.
  • Statin treatment appears to enhance endothelium-dependent vasodilation in coronary conductance vessels but not resistance vessels.
  • These findings suggest a potential benefit of statins in improving coronary blood flow to jeopardized myocardial regions.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...